Cliftonlarsonallen Wealth Advisors LLC grew its stake in Procter & Gamble Company (The) (NYSE:PG - Free Report) by 18.0% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 39,333 shares of the company's stock after purchasing an additional 6,009 shares during the period. Cliftonlarsonallen Wealth Advisors LLC's holdings in Procter & Gamble were worth $6,267,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds and other institutional investors have also modified their holdings of the stock. Benjamin Edwards Inc. increased its position in shares of Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after purchasing an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC increased its holdings in shares of Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors raised its stake in shares of Procter & Gamble by 6.0% in the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock valued at $8,677,000 after acquiring an additional 2,886 shares during the last quarter. Concurrent Investment Advisors LLC boosted its holdings in shares of Procter & Gamble by 26.4% in the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after acquiring an additional 25,059 shares in the last quarter. Finally, Kelly Financial Services LLC increased its holdings in Procter & Gamble by 8.7% during the 1st quarter. Kelly Financial Services LLC now owns 1,727 shares of the company's stock valued at $294,000 after purchasing an additional 138 shares in the last quarter. Institutional investors own 65.77% of the company's stock.
Procter & Gamble Stock Down 0.7%
Shares of NYSE PG opened at $152.06 on Friday. Procter & Gamble Company has a 1 year low of $149.91 and a 1 year high of $180.43. The firm's 50-day moving average is $155.63 and its 200-day moving average is $160.17. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. The firm has a market capitalization of $355.90 billion, a PE ratio of 23.36, a price-to-earnings-growth ratio of 4.04 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion for the quarter, compared to analyst estimates of $20.79 billion. During the same period in the prior year, the business posted $1.40 earnings per share. Procter & Gamble's revenue was up 1.7% compared to the same quarter last year. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 EPS for the current year.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Investors of record on Friday, July 18th were paid a dividend of $1.0568 per share. The ex-dividend date of this dividend was Friday, July 18th. This represents a $4.23 dividend on an annualized basis and a dividend yield of 2.8%. Procter & Gamble's payout ratio is 64.82%.
Analyst Ratings Changes
PG has been the topic of a number of recent analyst reports. BNP Paribas Exane reduced their price objective on Procter & Gamble from $177.00 to $172.00 and set an "outperform" rating on the stock in a research note on Tuesday, September 23rd. Barclays reduced their price target on shares of Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating on the stock in a research report on Wednesday. BNP Paribas restated an "outperform" rating and issued a $177.00 price objective on shares of Procter & Gamble in a research report on Friday, August 15th. JPMorgan Chase & Co. reaffirmed a "neutral" rating and issued a $170.00 target price (down from $178.00) on shares of Procter & Gamble in a research note on Friday, July 25th. Finally, Wells Fargo & Company lowered their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a report on Thursday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, eleven have given a Buy rating and eight have given a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $173.11.
Get Our Latest Stock Analysis on PG
Insiders Place Their Bets
In other Procter & Gamble news, CEO Sundar G. Raman sold 9,554 shares of the stock in a transaction dated Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,511,060.64. Following the transaction, the chief executive officer owned 41,886 shares of the company's stock, valued at approximately $6,624,689.76. This represents a 18.57% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Ma. Fatima Francisco sold 9,100 shares of the firm's stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total value of $1,431,157.00. Following the transaction, the chief executive officer owned 27,295 shares in the company, valued at approximately $4,292,684.65. This trade represents a 25.00% decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 120,181 shares of company stock valued at $18,918,012 in the last ninety days. 0.20% of the stock is currently owned by insiders.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report